In:
Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 107, No. 16 ( 2003-04-29), p. 2102-2108
Abstract:
Background— Apoptosis of vascular endothelial cells (ECs) can be induced in vitro by experimentally modified LDL. Description of proapoptotic circulating lipoproteins may significantly enhance understanding of atherothrombosis pathophysiology. Methods and Results— Fast protein liquid chromatography of LDL samples from 7 asymptomatic, hypercholesterolemic patients yielded subfractions L 1 –L 5 in increasing electronegativity. L 4 and L 5 were not detectable or collectible in normolipidemic samples. In bovine aortic EC cultures, L 5 induced marked apoptosis and L 4 had a mild effect, whereas hypercholesterolemic or normolipidemic L 1 –L 3 had negligible effects. Compared with copper-oxidized LDL, L 5 was only mildly oxidized, although its propensity to form conjugated dienes in response to copper exceeded that of other subfractions. L 5 -induced apoptosis was associated with suppressed fibroblast growth factor 2 (FGF-2) transcription, as assessed by nuclear run-on analysis. Degrading platelet-activating factor (PAF)-like lipids in L 5 by a recombinant PAF acetylhydrolase prevented both FGF-2 downregulation and apoptosis. Furthermore, the ability of L 5 lipid extract to induce calcium influx into neutrophils was lost after pretreatment of the extract with PAF acetylhydrolase. FGF-2 supplementation, PAF receptor (PAFR) blockade with WEB-2086, and inactivation of PAFR-coupled G i protein with pertussis toxin all effectively attenuated L 5 -induced apoptosis. Conclusions— Our findings indicate that a highly electronegative, mildly oxidized LDL subfraction present in human hypercholesterolemic but not normolipidemic plasma can induce apoptosis in cultured ECs. The evidence that a freshly isolated LDL species modulates transcription of FGF-2 may provide a physiological insight into the mechanism of vascular EC apoptosis in hypercholesterolemia.
Type of Medium:
Online Resource
ISSN:
0009-7322
,
1524-4539
DOI:
10.1161/01.CIR.0000065220.70220.F7
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2003
detail.hit.zdb_id:
1466401-X
Permalink